How many insider declarations does Pharmanutra PR - First Sales on the US Market have?

Pharmanutra PR - First Sales on the US Market has filed 1 insider declaration with Consob.

Who is the top reporting insider at Pharmanutra PR - First Sales on the US Market?

The top reporting insider at Pharmanutra PR - First Sales on the US Market is Unknown, based on the count of public filings.

What is the net insider buy vs sell volume on Pharmanutra PR - First Sales on the US Market?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

Pharmanutra PR - First Sales on the US Market: directors' dealings · Italy · Consob

CONSOB:pharmanutra-pr-first-sales-on-the-us-marketIT·ConsobMcap 862M€Healthcare

AMF ↗

Explore the full management transaction log of Pharmanutra PR - First Sales on the US Market, a listed equity based in Italy. Shares are listed on IT IT, under the oversight of Consob. Operating in the Healthcare sector, Pharmanutra PR - First Sales on the US Market has recorded 1 reports. Market capitalisation: €861.8m. The latest transaction was disclosed on 3 October 2023 (Other). Among the most active insiders: Unknown. Every trade is accessible without an account.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

Analyst consensus

3 analysts

Strong buy

76.00 €Target 81.33 €86.00 €

Valuation

PER (trailing)40.9x

PER (forward)29.4x

P/Book12.1x

Balance sheet & cash

Market cap861.8 M€

Debt / Equity26%

Profitability & ownership

ROE30.1%

ROA15.1%

% insiders65.0%

% institutions16.1%

Last declaration on 3 October 2023

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations